cisplatinum


Also found in: Medical, Wikipedia.

cis·plat·i·num

 (sĭs-plăt′n-əm)
n.

[cis(-diaminedichloro)platinum.]
Mentioned in ?
References in periodicals archive ?
section]) Diabetes mellitus, cisplatinum chemotherapy, anorexia nervosa (all n = 1).
Initially, cisplatinum was used as a single agent in the neoadjuvant setting.
These include transarterial chemoembolization, radioactive yttrium-impregnated class microspheres, targeted radiation therapies, laser beam therapies, and cisplatinum gel injection.
A similar observation was reported by Hill et al, who found that the combination of cisplatinum and 5-fluorouracil resulted in no major improvement in survival or symptom control in patients with ACC.
Antitumor activity of a new platinum complex: an experimental and clinical appraisal and preliminary comparison with cisplatinum and carboplatinum.
An article on UESL from a developing country details the successful treatment of 3 patients with cisplatinum, bleomycin and etoposide, [20] a course of treatment which may have been chosen for its comparatively low cost, despite the incidence of pulmonary fibrosis which limits use of bleomycin in better-resourced centres.
In mesothelioma, TRAIL has been shown to enhance the chemosensitivity of tumor cells to various therapeutic agents, such as doxorubicin, gemcitabine, cisplatinum, or etoposide.
4E-2 CT, chemotherapy; Dec, decrease; DX, nasopharyngeal carcinoma at diagnosis; EP cohort, cohort of patients treated by chemotherapy with Etoposide and Cisplatinum for relapse; GC cohort, cohort of patients treated by chemotherapy with Gemcitabine & Cisplatinum for relapse; Inc, increase; NA, not applicable; NPC, nasopharyngeal carcinoma; NR, nonresponders in chemotherapy; REM, nasopharyngeal carcinoma patients in remission; RP, nasopharyngeal carcinoma patients in relapse; RS, responders in chemotherapy.
Major groups of traditional ototoxic agents in humans Aminoglycosides Cytotoxic agents Amikacin Bleomycin Dihydrostreptomycin Carboplatinum Gentamicin Cisplatinum Kanamycin Nitrogen mustard Neomycin Vincristine Netilmicin Streptomycin Others Tobramycin Acetylsalicylic acid Arsenicals Loop diuretics Quinine Table 2.
After receiving the first cycle of ifosfamide, adriamycin, and cisplatinum (IAP) chemotherapy, however, the patient absconded.
Encouraging preliminary data was presented from an ongoing Phase II trial combining Tarceva with cisplatinum and docetaxel in HNSCC.